Cargando…
High dose vitamin D(3) empowers effects of subcutaneous immunotherapy in a grass pollen-driven mouse model of asthma
Allergen-specific immunotherapy (AIT) has the potential to provide long-term protection against allergic diseases. However, efficacy of AIT is suboptimal, while application of high doses allergen has safety concerns. The use of adjuvants, like 1,25(OH)(2)VitD(3) (VitD3), can improve efficacy of AIT....
Autores principales: | Hesse, Laura, van Ieperen, N., Petersen, Arjen H., Elberink, J. N. G. Oude, van Oosterhout, Antoon J. M., Nawijn, Martijn C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705678/ https://www.ncbi.nlm.nih.gov/pubmed/33257771 http://dx.doi.org/10.1038/s41598-020-77947-6 |
Ejemplares similares
-
1,25(OH)(2)VitD3 supplementation enhances suppression of grass pollen-induced allergic asthma by subcutaneous and sublingual immunotherapy in a mouse model
por: Hesse, Laura, et al.
Publicado: (2020) -
Subcutaneous immunotherapy with purified Der p1 and 2 suppresses type 2 immunity in a murine asthma model
por: Hesse, L., et al.
Publicado: (2018) -
Subcutaneous immunotherapy using modified Phl p5a‐derived peptides efficiently alleviates allergic asthma in mice
por: Hesse, Laura, et al.
Publicado: (2019) -
Allergen-specific subcutaneous immunotherapy in allergic asthma: immunologic mechanisms and improvement
por: Taher, Yousef A., et al.
Publicado: (2010) -
Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma
por: Vogelberg, Christian, et al.
Publicado: (2020)